Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on July 22, 2003, to disclose its financial results for the quarter and six months ended June 30, 2003, via an attached press release (Exhibit 99.1). This filing is significant as it provides an update on the company's operational and financial performance during the second quarter of 2003. Investors can gain insights into the company's revenue, profitability, and any significant business developments announced during this period. The press release, incorporated by reference, serves as the primary source of detailed financial information. While the 8-K itself does not contain the full financial statements, it signals to investors that key performance indicators and business updates are being made public. Interested parties should refer to the referenced press release for specific figures and narrative explanations regarding Quest Diagnostics' performance.
Key Highlights
- 1Quest Diagnostics (DGX) filed an 8-K on July 22, 2003, reporting its financial results.
- 2The filing pertains to the quarter and six months ended June 30, 2003.
- 3Key financial and operational information is disclosed through an attached press release (Exhibit 99.1).
- 4The press release is incorporated by reference, making it an integral part of the filing.
- 5This 8-K serves as a Regulation FD disclosure, ensuring public dissemination of material information.
- 6Investors can access the specific quarterly and year-to-date financial performance details within the referenced press release.